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Background
Renal cell carcinoma (RCC) is the most common malig-
nancy of the adult kidney, comprising 3-4% of all human
cancers, ranked sixth-leading cause of cancer death and
incidences are increasing worldwide [1]. If detected in
early stages, it is potentially curable by surgical resection;
however, only a fraction of metastatic RCC is responsive
to treatment. The molecular events leading to disease
onset and progression are not well understood and needs
investigations.
Materials and methods
We performed whole gene expression profiling of RCC
(n=4) and normal renal tissue (n=5) using Affymetrix
HuGene 1.0 ST arrays. We retrieved selected expression
data from NCBI’s “Gene Expression Omnibus” database
(GSE781, GSE7023, and GSE6344) for comparative analysis
[2]. Ingenuity Pathway Analysis (Ingenuity System), a gen-
ome-wide biological pathway analysis package, was used to
find significantly molecular networks and pathways asso-
ciated with kidney cancer.
Results
We identified 1515 differentially expressed significant
genes, 967 up and 548 down regulated, with cutoff false
discovery rate ≤ 0.05 and a fold change > 2; comparing
RCC with normal kidney tissues. The most significantly
upregulated genes were topoisomerase DNA II binding
protein 1 (TOPBP1), tryptophan 2,3-dioxygenase (TDO2),
forkhead box M1 (FOXM1), ankyrin repeat domain 13A
(ANKRD13A), and potassium inwardly-rectifying channel
JI (KCNJ1) whereas downregulated genes were nephrosis2
(NPHS2), uromodulin (UMOD), calbindin1 (CALB1),
solute carrier family12 (SLC12A3), plasminogen (PLG).
We also found 781 genes to be common, comparing our
data with retrieved data. IPA based canonical pathway
analysis shown Atherosclerosis signaling, LXR/RXR activa-
tion, GM-CSF signaling, Notch Signaling, Leukocyte
Extravasation Signaling pathway to be significantly asso-
ciated with our kidney cancer cases and this finding is in
accordance with other finding [3-5].
Conclusions
Present study provides an initial overview of differentially
expressed genes in kidney cancer of Saudi Arabian
patients using whole transcript, high-density expression
arrays. Comparative analysis suggest that even though
data set is small but has a potential source for novel bio-
marker for kidney cancer and may offer unique biological
insights into these tumors. In conclusion, it is important
to study gene expression profiles comprehensively to
extract more sophisticated biological interpretations.
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